A comparison of retinal images taken by the new low-cost OCT system (l) and a
commercial device (r). In its first clinical
trial, the low-cost system produced images
of 120 retinas that were 95 percent as
sharp as those taken by current commercial systems, which was sufficient for accurate clinical diagnosis.